{"id":"clioquinol","rwe":[{"pmid":"41882943","year":"2026","title":"Temporally Controlled Interconversion Between Suprasome and Supracube Structures to Regulate Catalytic Activities.","finding":"","journal":"Chemistry (Weinheim an der Bergstrasse, Germany)","studyType":"Clinical Study"},{"pmid":"41765924","year":"2026","title":"Artificial intelligence versus traditional approaches in multicomponent spectral analysis.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"41704764","year":"2026","title":"KNSTRN knockdown impairs autophagy flux to inhibit bladder cancer progression.","finding":"","journal":"iScience","studyType":"Clinical Study"},{"pmid":"41580015","year":"2026","title":"Copper ionophores drive divergent responses to immune checkpoint inhibition across colorectal tumor models.","finding":"","journal":"Cancer letters","studyType":"Clinical Study"},{"pmid":"41465301","year":"2025","title":"Bifunctional BODIPY-Clioquinol Copper Chelator with Multiple Anti-AD Properties.","finding":"","journal":"International journal of molecular sciences","studyType":"Clinical Study"}],"_fda":{"id":"416176c4-52ba-8c6a-e063-6294a90a3584","set_id":"134a88a1-13e5-4da0-8270-c380b57aaeb7","openfda":{"nui":["N0000185508","N0000175629","N0000184306","M0000728","N0000175576","N0000175450"],"unii":["7BHQ856EJ5","WI4X0X7BPJ"],"route":["TOPICAL"],"rxcui":["1606483"],"spl_id":["416176c4-52ba-8c6a-e063-6294a90a3584"],"brand_name":["DERMOSCRIBE ICHYBUM"],"spl_set_id":["134a88a1-13e5-4da0-8270-c380b57aaeb7"],"package_ndc":["69683-101-11"],"product_ndc":["69683-101"],"generic_name":["HYDROCORTISONE, CLIOQUINOL, ZINC OXIDE"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Allergens [CS]"],"pharm_class_pe":["Increased Histamine Release [PE]","Cell-mediated Immunity [PE]"],"substance_name":["CLIOQUINOL","HYDROCORTISONE"],"pharm_class_epc":["Standardized Chemical Allergen [EPC]","Corticosteroid [EPC]"],"pharm_class_moa":["Corticosteroid Hormone Receptor Agonists [MoA]"],"manufacturer_name":["DERMOSCRIBE PTY LTD"],"application_number":["M015"],"is_original_packager":[true]},"purpose":["Purpose Pruritis ani (anal itching) cream"],"version":"11","warnings":["Warnings FOR EXTERNAL USE ONLY Ask a doctor before use if you are pregnant or breastfeeding, you are under 12 years of age, you have an infection affecting the anus or surrounding area e.e. a sexually transmitted disease, or tuberculosis Stop use and consult a doctor if condition worsens or does not improve after regular use as directed"],"effective_time":"20251017","active_ingredient":["Active ingredients HYDROCORTISONE 1% CLIOQUINOL 1%"],"inactive_ingredient":["INACTIVE INGREDIENTS Beeswax, Coconut Oil, Glycerine, Lanolin, Petrolatum, Shea Butter, Sweet Almond Oil, Tocopherol Acetate"],"recent_major_changes":["Updating Drug Facts"],"indications_and_usage":["Uses ICHYBUM is a medicated cream used to help relieve the symptoms of pruritis ani and other afflictions involving chronic itching around the anus"],"dosage_and_administration":["DIRECTIONS Apply a small amount once or twice daily, preferable after showering and or bowel movements and at night before sleep"],"spl_product_data_elements":["DERMOSCRIBE ICHYBUM HYDROCORTISONE, CLIOQUINOL, ZINC OXIDE GLYCERIN LANOLIN PETROLATUM HYDROCORTISONE HYDROCORTISONE BEESWAX CLIOQUINOL CLIOQUINOL COCONUT OIL SHEA BUTTER PRUNUS AMYGDALUS DULCIS (SWEET ALMOND) OIL ALPHA-TOCOPHEROL ACETATE"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN. If swallowed, seek medical advice"],"package_label_principal_display_panel":["Ichybum Tube Back View_Mar 2025 JPG"]},"tags":[{"label":"Standardized Chemical Allergen","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Amyloid beta A4 protein","category":"target"},{"label":"APP","category":"gene"},{"label":"D08AH30","category":"atc"},{"label":"Topical","category":"route"},{"label":"Cream","category":"form"},{"label":"Ointment","category":"form"},{"label":"Active","category":"status"},{"label":"Tinea corporis","category":"indication"},{"label":"Tinea cruris","category":"indication"},{"label":"Tinea pedis","category":"indication"}],"phase":"marketed","safety":{"boxedWarnings":[],"contraindications":["Adrenal cortical hypofunction","Atrophoderma","Open wound","Peripheral vascular disease","Telangiectasia disorder"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CLIOQUINOL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:26:45.899677+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Clioquinol","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T00:26:53.001293+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:26:51.604732+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CLIOQUINOL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:26:51.967245+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:26:44.571272+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:26:44.571297+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:26:44.571302+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Iron chelating agent","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:26:53.001240+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL497/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:26:52.662842+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M015","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:26:44.571304+00:00"}},"allNames":"cliquinol","offLabel":[],"synonyms":["clioquinol","chloroiodoquin","chloroiodoquine","cliquinol","iodochlorhydroxyquin"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Cliquinol","ecosystem":[{"indication":"Tinea corporis","otherDrugs":[{"name":"benzocaine","slug":"benzocaine","company":""},{"name":"betamethasone","slug":"betamethasone","company":""},{"name":"betamethasone dipropionate","slug":"betamethasone-dipropionate","company":"Schering"},{"name":"butenafine","slug":"butenafine","company":"Mylan"}],"globalPrevalence":null},{"indication":"Tinea cruris","otherDrugs":[{"name":"betamethasone","slug":"betamethasone","company":""},{"name":"betamethasone dipropionate","slug":"betamethasone-dipropionate","company":"Schering"},{"name":"butenafine","slug":"butenafine","company":"Mylan"},{"name":"ciclopirox","slug":"ciclopirox","company":"Medimetriks Pharms"}],"globalPrevalence":null},{"indication":"Tinea pedis","otherDrugs":[{"name":"benzocaine","slug":"benzocaine","company":""},{"name":"betamethasone","slug":"betamethasone","company":""},{"name":"betamethasone dipropionate","slug":"betamethasone-dipropionate","company":"Schering"},{"name":"butenafine","slug":"butenafine","company":"Mylan"}],"globalPrevalence":null}],"mechanism":{"target":"Amyloid beta A4 protein","novelty":"First-in-class","targets":[{"gene":"APP","source":"DrugCentral","target":"Amyloid beta A4 protein","protein":"Amyloid beta A4 protein"}],"modality":"Small Molecule","drugClass":"Standardized Chemical Allergen [EPC]","explanation":"","oneSentence":"","technicalDetail":"Cliquinol's exact mechanism of action is not fully understood, but it is thought to involve the inhibition of fungal cell wall synthesis and the disruption of fungal membrane function, ultimately leading to the death of fungal cells."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Clioquinol","title":"Clioquinol","extract":"Clioquinol (iodochlorhydroxyquin) tradename Entero-Vioform is an antifungal drug and antiprotozoal drug. It is neurotoxic in large doses. It is a member of a family of drugs called hydroxyquinolines which inhibit certain enzymes related to DNA replication. The drugs have been found to have activity against both viral and protozoal infections."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/681","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CLIOQUINOL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CLIOQUINOL","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Clioquinol","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T10:08:36.595799","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:26:54.676083+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"oxyquinoline","drugSlug":"oxyquinoline","fdaApproval":"","relationship":"same-class"}],"genericName":"clioquinol","indications":{"approved":[{"name":"Tinea corporis","source":"DrugCentral","snomedId":84849002,"regulator":"FDA","eligibility":"No specific eligibility criteria mentioned"},{"name":"Tinea cruris","source":"DrugCentral","snomedId":399029005,"regulator":"FDA","eligibility":"No specific eligibility criteria mentioned"},{"name":"Tinea pedis","source":"DrugCentral","snomedId":6020002,"regulator":"FDA","eligibility":"No specific eligibility criteria mentioned"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"oxyquinoline","brandName":"oxyquinoline","genericName":"oxyquinoline","approvalYear":"","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT04220554","phase":"NA","title":"Improvement of Psoriasis Patients' Adherence to Topical Drugs","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2020-06-19","conditions":["Psoriasis Vulgaris"],"enrollment":103,"completionDate":"2022-06-01"},{"nctId":"NCT05727943","phase":"PHASE2","title":"Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study","status":"UNKNOWN","sponsor":"KU Leuven","startDate":"2022-03-01","conditions":["Epilepsy Intractable"],"enrollment":10,"completionDate":"2023-12-31"},{"nctId":"NCT05105139","phase":"","title":"Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2021-11-29","conditions":["Seborrheic Dermatitis","Psoriasis of Scalp"],"enrollment":90,"completionDate":"2022-02-25"},{"nctId":"NCT01429701","phase":"PHASE3","title":"Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous","status":"COMPLETED","sponsor":"EMS","startDate":"2012-05","conditions":["Eczema"],"enrollment":76,"completionDate":"2012-08"},{"nctId":"NCT03188549","phase":"PHASE4","title":"Magen Haim Project - Assessing Hand Hygiene Formulas","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2017-06-15","conditions":["Comparing Use of Hand Hygiene Products"],"enrollment":1505,"completionDate":"2019-01-15"},{"nctId":"NCT00963495","phase":"PHASE1","title":"Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy","status":"TERMINATED","sponsor":"University Health Network, Toronto","startDate":"2009-08","conditions":["Acute Myeloid Leukemia","Acute Lymphocytic Leukemia","Chronic Lymphocytic Leukemia","Myelodysplasia","Lymphoma, Non-Hodgkin","Hodgkin's Lymphoma","Multiple Myeloma"],"enrollment":11,"completionDate":"2013-09"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Topical","formulation":"Cream, Ointment","formulations":[{"form":"CREAM","route":"TOPICAL","productName":"DERMOSCRIBE ICHYBUM"},{"form":"OINTMENT","route":"TOPICAL","productName":"DERMOSCRIBE DIAPER"}]},"crossReferences":{"NUI":"N0000146888","MMSL":"4470","NDDF":"002874","UNII":"7BHQ856EJ5","VUID":"4018572","CHEBI":"CHEBI:74460","VANDF":"4018572","INN_ID":"2116","RXNORM":"5942","UMLSCUI":"C0021978","chemblId":"CHEMBL497","ChEMBL_ID":"CHEMBL497","KEGG_DRUG":"D03538","DRUGBANK_ID":"DB04815","PDB_CHEM_ID":" CQL","PUBCHEM_CID":"2788","SNOMEDCT_US":"387291001","MESH_DESCRIPTOR_UI":"D007464"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":698,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"D08AH30","allCodes":["D08AH30","D09AA10","G01AC02","P01AA02","P01AA52","S02AA05"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 25","pmid":"41882943","title":"Temporally Controlled Interconversion Between Suprasome and Supracube Structures to Regulate Catalytic Activities.","journal":"Chemistry (Weinheim an der Bergstrasse, Germany)"},{"date":"2026 Mar 1","pmid":"41765924","title":"Artificial intelligence versus traditional approaches in multicomponent spectral analysis.","journal":"Scientific reports"},{"date":"2026 Feb 20","pmid":"41704764","title":"KNSTRN knockdown impairs autophagy flux to inhibit bladder cancer progression.","journal":"iScience"},{"date":"2026 Mar 31","pmid":"41580015","title":"Copper ionophores drive divergent responses to immune checkpoint inhibition across colorectal tumor models.","journal":"Cancer letters"},{"date":"2025 Dec 9","pmid":"41465301","title":"Bifunctional BODIPY-Clioquinol Copper Chelator with Multiple Anti-AD Properties.","journal":"International journal of molecular sciences"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1934","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:26:54.676083+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}